Petr Jansa

Vice President, Head of Chemistry BridGene Biosciences Inc.

Seminars

Thursday 22nd October 2026
Proteome-Wide Live-Cell Covalent Screening Reveals Physicochemical Drivers of Promiscuous Labeling & Design Principles for Selective Covalent Libraries
9:30 am
  • Introducing the IMTAC TM proteome-wide cell-based screening platform
  • Interrogating proteome-wide screening data to characterize compound reactivity and uncover patterns that contribute to selectivity or promiscuity of covalent compounds
  • Refining covalent library design strategies to minimize promiscuity and eliminate nonproductive compounds, enabling more efficient, higher-quality hit identification
Petr Jansa Bridgene- speaker for 4th Covalent Drug Discovery & Development Summit